DHR vs ELDN · P/E 39, rev $24.57B vs $209.6M cap
Danaher Corporation (DHR) versus Eledon Pharmaceuticals Inc (ELDN) — a side-by-side from cached financials, not a winner call.
Danaher Corporation (DHR) is a diagnostics & research company listed on US.
Eledon Pharmaceuticals Inc (ELDN) is a biotechnology company listed on US.
Latest reported DHR revenue for 2025-12-31 was $24.57B. Net income was $3.61B. Revenue was up 2.9% from 2024-12-31 to 2025-12-31. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
ELDN does not have a complete income-statement cache yet.
DHR currently screens at market cap $144.18B and trailing P/E 39.0. ELDN currently screens at market cap $209.6M.
Not investment advice. Open the DHR and ELDN stock pages for the full models.
Not investment advice.